Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic Factors of Patients with Advanced Gallbladder Carcinoma Following Aggressive Surgical Resection

(2011) Yoshiaki Murakami et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Is Para-aortic Lymph Node Metastasis a Contraindication for Radical Resection in Biliary Carcinoma?

(2011) Yoshiaki Murakami et al.   WORLD JOURNAL OF SURGERY

Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma

(2010) Yoshiaki Murakami et al.   ANNALS OF SURGICAL ONCOLOGY

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

(2010) T Okusaka et al.   BRITISH JOURNAL OF CANCER

A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer

(2010) Masashi Kanai et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Gemcitabine Plus S-1 Chemotherapy Improves Survival After Aggressive Surgical Resection for Advanced Biliary Carcinoma

(2009) Yoshiaki Murakami et al.   ANNALS OF SURGERY

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer

(2009) Takashi Sasaki et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma

(2009) Yoshiaki Murakami et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Surgical Outcomes and Prognostic Factors for T2 Gallbladder Cancer Following Surgical Resection

(2009) Sae Byeol Choi et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience

(2009) Sung Gyu Lee et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Efficacy and Safety of S-1 Monotherapy in Patients with Advanced Biliary Tract Adenocarcinoma

(2009) Inkeun Park et al.   ONCOLOGY

Epidemiology of biliary tract cancers: an update

(2008) G. Randi et al.   ANNALS OF ONCOLOGY

Surgical Treatment of Mass-Forming Intrahepatic Cholangiocarcinoma: An 11-Year Western Single-Center Experience in 107 Patients

(2008) Süleyman Yedibela et al.   ANNALS OF SURGICAL ONCOLOGY

Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone

(2008) Yerko Borghero et al.   ANNALS OF SURGICAL ONCOLOGY

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study

(2008) Junji Furuse et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Indication for Postoperative Adjuvant Therapy in Biliary Carcinoma Based on Analysis of Recurrence and Survival After Surgical Resection

(2008) Yoshiaki Murakami et al.   DIGESTIVE DISEASES AND SCIENCES

Role of Adjuvant Chemoradiation Therapy in Adenocarcinomas of the Ampulla of Vater

(2008) Sunil Krishnan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma

(2008) John W. Nelson et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS